ANDROGEL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Estonia, France, Hong Kong SAR China, Ireland, Israel, Netherlands, Nigeria, Romania, Singapore, South Africa.

Active ingredients

The drug ANDROGEL contains one active pharmaceutical ingredient (API):

1
UNII 3XMK78S47O - TESTOSTERONE
 

Testosterone, secreted by the testes and its major metabolite dihydrotestosterone (DHT), is responsible for the development of the external and internal genital organs and for maintaining the secondary sexual characteristics (stimulating hair growth, deepening of the voice, development of the libido); for a general effect on protein anabolism; for development of skeletal muscle and body fat distribution; for a reduction in urinary nitrogen, sodium, potassium, chloride, phosphate and water excretion.

 
Read more about Testosterone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ANDROGEL 1% Gel MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G03BA03 Testosterone G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03B Androgens → G03BA 3-oxoandrosten (4) derivatives
Discover more medicines within G03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 542214120000405, 542214120000505
CA Health Products and Food Branch 02245345, 02245346, 02249499
EE Ravimiamet 1195253
FR Base de données publique des médicaments 64205548, 68097237
HK Department of Health Drug Office 57973, 57974
HR Agencija za lijekove i medicinske proizvode HR-H-864783232
IL מִשְׂרַד הַבְּרִיאוּת 4677
NG Registered Drug Product Database C4-1623
Switch country to Nigeria in order to find specific presentations of ANDROGEL
NL Z-Index G-Standaard 14943581
NL Z-Index G-Standaard, PRK 131865, 74225
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W62752001, W62752002, W62752003, W62752004
SG Health Sciences Authority 13161P, 13162P
US FDA, National Drug Code 0051-8425, 0051-8450, 0051-8462
ZA Health Products Regulatory Authority A40/21.7/0260

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.